Public Health Industrial Base Capabilities and Capacities: Essential Medicines

Title: Public Health Industrial Base Capabilities and Capacities: Essential Medicines

As set forth in FAR 15.201(e), the intent of this RFI is to gather market research on the domestic production capability and capacity of the Public Health Industrial Base (PHIB) as it relates to the list of essential medicines identified pursuant to section 3(c) of Executive Order 13944 of August 6, 2020. This RFI is requesting data and information that would ensure HHS/ASPR’s Center for Industrial Base Management and Supply Chain (ASPR-IBMSC) better understands the PHIB capabilities and capacities used to produce and supply drug and biologic essential medicines identified, as of the date of Presidential Determination 2024-03 of December 27, 2023, pursuant to section (c) of Executive Order 13944 of August 6, 2020, and Executive Order 14293 of May 5, 2025.

ASPR-IBMSC intends to use electronic mail for all correspondence regarding this RFI. Electronic responses to this RFI are due no later than 5 P.M. ET on June 16, 2025.

Documentation shall be submitted to the following individual the Contracting Point of Contact: Lori Fischer at lori.fischer@hhs.gov and Roger Henriquez at roger.henriquez@hhs.gov and also submit your response at the main email account at IBMSC-Submissions@hhs.gov.

Please include RFI No./Title in the subject line of the email and all correspondence concerning this RFI.

Please see the attached full RFI document titled, "ASPR IBMSC RFI_Priority EMs.pdf".